Daiichi Sankyo Company, Limited (DSNKY) Financials

DSNKY Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 24.4 billion 13.5 billion
Sept. 30, 2025 24.1 billion 12.9 billion
June 30, 2025 24.1 billion 13.1 billion
March 31, 2025 23.1 billion 12.3 billion

DSNKY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 346.4 million ?
Sept. 30, 2025 -209.9 million ?
June 30, 2025 -454.0 million ?
March 31, 2025 239.1 million ?

DSNKY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 563.0 million
Sept. 30, 2025 311.5 million
June 30, 2025 594.5 million
March 31, 2025 583.5 million

DSNKY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 3.5 billion 1.9 billion -
Sept. 30, 2025 4.0 billion 680.7 million -
June 30, 2025 4.0 billion 701.2 million -
March 31, 2025 4.8 billion 675.8 million -

DSNKY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 11.8 million
Sept. 30, 2025 12.5 million
June 30, 2025 12.9 million
March 31, 2025 12.6 million

DSNKY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 199.9 million 793.5 million 1.5 billion -
Sept. 30, 2025 268.6 million 768.0 million 1.3 billion -
June 30, 2025 199.7 million 736.7 million 1.3 billion -
March 31, 2025 243.7 million 892.6 million 1.4 billion -

DSNKY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 3.6 billion 768.6 million
Sept. 30, 2025 3.4 billion 1.1 billion
June 30, 2025 3.3 billion 642.1 million
March 31, 2025 3.5 billion 631.6 million

DSNKY

Price: $15.31

52 week price:
15.10
27.50

Dividend Yield: 3.15%

Payout Ratio Range:
-437.46%
534.62%

Dividend Per Share: 0.49 USD

Earnings Per Share: 0.94 USD

P/E Ratio: 17.61

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 28.1 billion

Links: